Maxlinear, Inc: Form 10-K for the period ended Dec 31, 2014
Filed with the SEC on Feb 23, 2015 and accepted by EDGAR at Feb 23, 2015, 17:02 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2014-10-01 to 2014-12-31 | $32.5m | us-gaap:SalesRevenueNet |
| Revenue | 12 months2014-01-01 to 2014-12-31 | $133.1m | us-gaap:SalesRevenueNet |
| Cost of revenue | 12 months2014-01-01 to 2014-12-31 | $51.2m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2014-10-01 to 2014-12-31 | $19.8m | us-gaap:GrossProfit |
| Gross profit | 12 months2014-01-01 to 2014-12-31 | $82.0m | us-gaap:GrossProfit |
| Selling, general and administrative | 12 months2014-01-01 to 2014-12-31 | $34.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2014-01-01 to 2014-12-31 | −$8.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2014-01-01 to 2014-12-31 | $15.0k | us-gaap:InterestExpense |
| Income tax | 12 months2014-01-01 to 2014-12-31 | −$1.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2014-10-01 to 2014-12-31 | −$2.4m | us-gaap:NetIncomeLoss |
| Net income | 12 months2014-01-01 to 2014-12-31 | −$7.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2014-10-01 to 2014-12-31 | −$0.06 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2014-01-01 to 2014-12-31 | −$0.19 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2014-10-01 to 2014-12-31 | −$0.06 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2014-01-01 to 2014-12-31 | −$0.19 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2014-01-01 to 2014-12-31 | 36,472,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2014-01-01 to 2014-12-31 | $12.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2014-01-01 to 2014-12-31 | $8.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months2014-01-01 to 2014-12-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2014-12-31 | $20.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-12-31 | $100.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2014-12-31 | $135.7m | us-gaap:Assets |
| Current liabilities | At period end2014-12-31 | $33.2m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2014-12-31 | $99.1m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001288469-15-000002. Last ingested by Listed: Oct 30, 2026, 12:40 ET. Listed shows no prices and gives no investment advice.